Cassava Sciences Releases New Corporate Presentation
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cassava Sciences ( (SAVA) ) has shared an update.
Cassava Sciences, Inc. has released a corporate presentation available in the ‘Investors’ section of its website. This presentation is part of a Form 8-K filing, but the information is not considered ‘filed’ under the Securities Exchange Act of 1934 and is not subject to its liabilities.
The most recent analyst rating on (SAVA) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Cassava Sciences stock, see the SAVA Stock Forecast page.
Spark’s Take on SAVA Stock
According to Spark, TipRanks’ AI Analyst, SAVA is a Neutral.
Cassava Sciences faces significant financial challenges with no revenue and ongoing operational losses, reflected in the low financial performance score. Technical indicators show bearish trends, and the negative P/E ratio emphasizes valuation concerns. However, the strategic license agreement with Yale University could offer future growth potential, though it currently holds minimal weight due to its speculative nature.
To see Spark’s full report on SAVA stock, click here.
More about Cassava Sciences
Average Trading Volume: 859,623
Technical Sentiment Signal: Sell
Current Market Cap: $104.3M
For detailed information about SAVA stock, go to TipRanks’ Stock Analysis page.
